Given the synergistic epidemics of HIV and TB in southern Africa, the question of how and when to integrate HIV and TB treatment in co-infected patients is a critical one. Here at the Conference on Retroviruses and Opportunistic Infections, Drs. Diane Havlir and Salim Abdool Karim presented important results from two randomized clinical trials attempting […]
In the second of a two-part series with TB and HIV experts at the Bill & Melinda Gates Foundation, John Donnelly speaks with Dr. Peter Small, who runs the tuberculosis program at the Gates Foundation, regarding his thoughts on recent developments in the field of TB control and treatment, including the promise of the Gene Xpert rapid TB diagnostic tool. Dr. Small is a member of the Stop TB Partnership’s Coordinating Board, has done extensive research in the genetic variability of tuberculosis, and is a global expert in TB epidemiology, biology and control.
In the first of a two-part series with TB and HIV experts at the Bill & Melinda Gates Foundation, Dr. Stefano Bertozzi, director of HIV and tuberculosis programs at the Foundation, gives his thoughts on what lies ahead this year in HIV and TB building on key developments from the past year and a half. In his role, Dr. Bertozzi oversees grants in HIV vaccine development, biomedical prevention research, diagnostics development and resistance monitoring, and strategies for introduction and scaling-up of interventions. He has held past leadership roles at UNAIDS, the World Health Organization, the World Bank, and the National Institute of Public Health (INSP) in Mexico.
In a prestigious lecture to the National Institutes of Health (NIH) scientific community Tuesday, U.S. Agency on International Development (USAID) Administrator Rajiv Shah spoke about efficiencies that can be gained under the Global Health Initiative (GHI) and a renewed focus on “facilitating a continuum of invention and innovation from bench to bush,” at the agency.
In a presentation made to TB advocates and implementers, representatives from the U.S. Agency for International Development’s (USAID) Bureau for Global Health described the range of cuts its TB programs would experience if flat funded at the fiscal year (FY) 2010 level, or a reduction to the FY 2008 level. These budgetary scenarios were presented as […]
The U.S. Agency on International Development (USAID) issued a report to Congress entitled “Health Related Research and Development Activities at USAID – An Update on the Five-year Strategy, 2006 – 2010” and has been releasing the report to the public in increments since October. Science Speaks reported on the release of the AIDS research chapter […]
Cepheid, a California-based molecular diagnostics company, and the Foundation for Innovative New Diagnostics (FIND) announced a new collaboration to accelerate the development of a rapid HIV viral load test. This viral load test will run on the platform of Cepheid’s GeneXpert, the ground-breaking rapid test to diagnose drug-susceptible and drug-resistant tuberculosis. Given the high rates […]
With an enormous rebuild still needed in Haiti after the devastating earthquake last January, housing is in high demand in the small island country. This demand, coupled with the need to suppress the spread of tuberculosis, inspired the open innovation project Kay e Santen an Ayiti (Creole for “Housing and Health in Haiti”) sponsored by […]